Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.
about
Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung CancerCaffeic Acid phenethyl ester is a potential therapeutic agent for oral cancerAndrogen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2.Selective fraction of Atractylodes lancea (Thunb.) DC. and its growth inhibitory effect on human gastric cancer cells.Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signalingCaffeic acid phenethyl ester suppresses proliferation and survival of TW2.6 human oral cancer cells via inhibition of Akt signalingCholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cellsCurcumin increases exosomal TCF21 thus suppressing exosome-induced lung cancer.Modulatory Effects of Curcumin and Tyrphostins (AG494 and AG1478) on Growth Regulation and Viability of LN229 Human Brain Cancer Cells.Saurolactam Inhibits Proliferation, Migration, and Invasion of Human Osteosarcoma Cells.Curcumin inhibits proliferation-migration of NSCLC by steering crosstalk between a Wnt signaling pathway and an adherens junction via EGR-1.Curcumin combined with oxaliplatin effectively suppress colorectal carcinoma in vivo through inducing apoptosis.Chemopreventive effects of curcumin on chemically induced mouse skin carcinogenesis in BK5.insulin-like growth factor-1 transgenic mice.Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells.Encapsulation of curcumin within poly(amidoamine) dendrimers for delivery to cancer cells.Synergistic effect of fenretinide and curcumin for treatment of non-small cell lung cancer.
P2860
Q26740210-F62C2E00-B54D-4992-AB8F-92D3CBAAA1B2Q26822487-22D94318-D577-4ED8-A8CB-58ACF8AB1E15Q34278855-A3D2F364-9DA2-414F-9C2E-438E32634A9BQ34657592-C9BE5566-58FA-4C8A-A56F-FEA3CB3E0BCDQ35740051-93878E6C-B72F-4E49-9693-E161D7D9A336Q36790229-D9A44502-3A25-498B-900F-4D885FC2ABFFQ36913495-E492AACE-7052-4C42-BD2C-E30FD27F715AQ36926791-EDA72869-C3B1-45B8-9E2D-00825254C718Q37699374-06C3C71A-0833-4BE7-A509-22A94525D5F9Q38835764-1CD1721A-0439-4BA8-9DA3-2D842D2D6015Q38915850-6BB26102-671A-4AA3-91F3-64F5F47B4D9BQ38921106-85BBE392-952B-4C45-A243-A87DDB50FFA6Q38938309-3F4AEAA4-A273-4C75-8424-F4940B4AE1A7Q38975030-AD3FAA63-2E07-48C1-894B-C3D788A198BEQ39110498-26C2D898-24F5-47C2-8B2F-A70319E6D261Q39137808-F2EC0074-5C77-4534-9818-621D0391C994Q41573464-FFD13FD4-11FD-4956-BB51-02FEA24211E6
P2860
Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Combined treatment of curcumin ...... -small-cell lung cancer cells.
@en
Combined treatment of curcumin ...... -small-cell lung cancer cells.
@nl
type
label
Combined treatment of curcumin ...... -small-cell lung cancer cells.
@en
Combined treatment of curcumin ...... -small-cell lung cancer cells.
@nl
prefLabel
Combined treatment of curcumin ...... -small-cell lung cancer cells.
@en
Combined treatment of curcumin ...... -small-cell lung cancer cells.
@nl
P2093
P2860
P356
P1476
Combined treatment of curcumin ...... -small-cell lung cancer cells.
@en
P2093
Chih-Pin Chuu
Hui-Ping Lin
Li-Kuo Kuo
P2860
P304
P356
10.1002/PTR.3523
P577
2011-05-12T00:00:00Z